About LEM domain-containing protein 2
LEM domain-containing protein 2 (LEMD2) is a protein
from Homo sapiens identified by UniProt accession
Q8NC56, 503 residues long.
MolForge cross-references it against 0 known binders and
274 disease associations.
Target properties
| Protein name | LEM domain-containing protein 2 |
| UniProt accession | Q8NC56 |
| Gene | LEMD2 |
| Organism | Homo sapiens |
| Length | 503 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (274)
Diseases linked to this target (Open Targets).
- cataract 46 juvenile-onset · score 0.50
- early-onset non-syndromic cataract · score 0.38
- total early-onset cataract · score 0.37
- Growth delay · score 0.27
- Narrow mouth · score 0.27
- Triangular face · score 0.27
- Dental crowding · score 0.27
- Microcephaly · score 0.27
- Proptosis · score 0.27
- Micrognathia · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NC56-F1 | alphafold | PREDICTED | 70.31 | — |
Amino-acid sequence (503 residues)
MAGLSDLELR RELQALGFQP GPITDTTRDV YRNKLRRLRG EARLRDEERL REEARPRGEE RLREEARLRE DAPLRARPAA ASPRAEPWLS QPASGSAYAT PGAYGDIRPS AASWVGSRGL AYPARPAQLR RRASVRGSSE EDEDARTPDR ATQGPGLAAR RWWAASPAPA RLPSSLLGPD PRPGLRATRA GPAGAARARP EVGRRLERWL SRLLLWASLG LLLVFLGILW VKMGKPSAPQ EAEDNMKLLP VDCERKTDEF CQAKQKAALL ELLHELYNFL AIQAGNFECG NPENLKSKCI PVMEAQEYIA NVTSSSSAKF EAALTWILSS NKDVGIWLKG EDQSELVTTV DKVVCLESAH PRMGVGCRLS RALLTAVTNV LIFFWCLAFL WGLLILLKYR WRKLEEEEQA MYEMVKKIID VVQDHYVDWE QDMERYPYVG ILHVRDSLIP PQSRRRMKRV WDRAVEFLAS NESRIQTESH RVAGEDMLVW RWTKPSSFSD SER
Explore LEM domain-containing protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets